RxDoctor Payments Data

Kerry Mackey

Physician Assistant · Raleigh, NCNPI 1417599580

Payments from drug & device makers

$8,179in general payments, 2019–2025

Across 84 payments — averaging $97.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Otsuka America Pharmaceutical, Inc.$208
  • Supernus Pharmaceuticals, Inc.$196
  • Axsome Therapeutics, Inc.$125
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$116
  • Corium, LLC$116
  • plus $560 from 13 others

What the payments were for

  • Speaking & faculty fees$6,30077%
  • Food & beverage$1,87923%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,179 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$19,175
Medicare patients
85
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$16,926
Lisdexamfetamine Dimesylate12$2,327
Bupropion XlBupropion Hcl60$1,621
Lamotrigine ErLamotrigine13$1,576
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine54$1,416
Trazodone Hcl51$1,269
Duloxetine Hcl32$863
Buspirone Hcl40$691
Methylphenidate Hcl27$661
Quetiapine Fumarate29$601
Vilazodone Hcl12$535
Lamotrigine41$502
Olanzapine18$440
Albuterol Sulfate HfaAlbuterol Sulfate12$424
Escitalopram Oxalate36$393

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$208$16,92612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →